Clinical Trial Update: Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating acetylsalicylic acid and eflornithine for high-risk colorectal cancer patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenomatous Polyp
• Colorectal Cancer

Drugs mentioned

• Acetylsalicylic acid (Aspirin)
• Eflornithine (eflornithine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenomatous Polyp | Phase 2 | Status: COMPLETED | Results posted: 2018-04-30